Dr Mary Elizabeth Garman, MD - Medicare Dermatology in Pasadena, TX

Dr Mary Elizabeth Garman, MD is a medicare enrolled "Dermatology" physician in Pasadena, Texas. She went to Baylor College Of Medicine and graduated in 2002 and has 22 years of diverse experience with area of expertise as Dermatology. She is a member of the group practice Southeast Dermatology, P.a. and her current practice location is 4419 Crenshaw Rd, Pasadena, Texas. You can reach out to her office (for appointments etc.) via phone at (281) 991-5944.

Dr Mary Elizabeth Garman is licensed to practice in Texas (license number M2956) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1346277381.

Contact Information

Dr Mary Elizabeth Garman, MD
4419 Crenshaw Rd,
Pasadena, TX 77504-3628
(281) 991-5944
(281) 991-6849



Physician's Profile

Full NameDr Mary Elizabeth Garman
GenderFemale
SpecialityDermatology
Experience22 Years
Location4419 Crenshaw Rd, Pasadena, Texas
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Mary Elizabeth Garman attended and graduated from Baylor College Of Medicine in 2002
  NPI Data:
  • NPI Number: 1346277381
  • Provider Enumeration Date: 06/26/2006
  • Last Update Date: 07/08/2011
  Medicare PECOS Information:
  • PECOS PAC ID: 7113920976
  • Enrollment ID: I20060816000373

Medical Identifiers

Medical identifiers for Dr Mary Elizabeth Garman such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1346277381NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207N00000XDermatology M2956 (Texas)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Southeast Dermatology, P.a.519371557111

News Archive

Celltrion receives approval for infliximab biosimilar antibody from Brazil's ANVISA

Hospira, Inc., a global leader in biosimilars, today announced that its partner, Celltrion – a global biopharmaceutical company – has received approval from ANVISA – the National Health Surveillance Agency in Brazil – for Remsima (infliximab), the first biosimilar monoclonal antibody approved for use in Brazil.

Medical practice evolves: Prescribing habits, doc-patient relationship, health law changes

A push to treat chronic pain and financial disincentives for treating addiction may pressure clinicians into prescribing opioids for patients who are already addicted, a researcher suggested.

Scientists study effects of eating breakfast versus fasting overnight before exercise

Eating breakfast before exercise may "prime" the body to burn carbohydrates during exercise and more rapidly digest food after working out, University of Bath researchers have found.

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

Neuroscape Psychedelics Division at UCSF to advance psychedelics research and therapies

Psychedelics research in support of brain health is getting a major boost this month with the formation of the Neuroscape Psychedelics Division at the University of California, San Francisco.

Read more Medical News

› Verified 3 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Mary Elizabeth Garman allows following entities to bill medicare on her behalf.
Entity NameSoutheast Dermatology, P.a.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1811932205
PECOS PAC ID: 5193715571
Enrollment ID: O20040517000995

News Archive

Celltrion receives approval for infliximab biosimilar antibody from Brazil's ANVISA

Hospira, Inc., a global leader in biosimilars, today announced that its partner, Celltrion – a global biopharmaceutical company – has received approval from ANVISA – the National Health Surveillance Agency in Brazil – for Remsima (infliximab), the first biosimilar monoclonal antibody approved for use in Brazil.

Medical practice evolves: Prescribing habits, doc-patient relationship, health law changes

A push to treat chronic pain and financial disincentives for treating addiction may pressure clinicians into prescribing opioids for patients who are already addicted, a researcher suggested.

Scientists study effects of eating breakfast versus fasting overnight before exercise

Eating breakfast before exercise may "prime" the body to burn carbohydrates during exercise and more rapidly digest food after working out, University of Bath researchers have found.

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

Neuroscape Psychedelics Division at UCSF to advance psychedelics research and therapies

Psychedelics research in support of brain health is getting a major boost this month with the formation of the Neuroscape Psychedelics Division at the University of California, San Francisco.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Mary Elizabeth Garman is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Mary Elizabeth Garman, MD
4419 Crenshaw Rd,
Pasadena, TX 77504-3628

Ph: (281) 991-5944
Dr Mary Elizabeth Garman, MD
4419 Crenshaw Rd,
Pasadena, TX 77504-3628

Ph: (281) 991-5944

News Archive

Celltrion receives approval for infliximab biosimilar antibody from Brazil's ANVISA

Hospira, Inc., a global leader in biosimilars, today announced that its partner, Celltrion – a global biopharmaceutical company – has received approval from ANVISA – the National Health Surveillance Agency in Brazil – for Remsima (infliximab), the first biosimilar monoclonal antibody approved for use in Brazil.

Medical practice evolves: Prescribing habits, doc-patient relationship, health law changes

A push to treat chronic pain and financial disincentives for treating addiction may pressure clinicians into prescribing opioids for patients who are already addicted, a researcher suggested.

Scientists study effects of eating breakfast versus fasting overnight before exercise

Eating breakfast before exercise may "prime" the body to burn carbohydrates during exercise and more rapidly digest food after working out, University of Bath researchers have found.

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

Neuroscape Psychedelics Division at UCSF to advance psychedelics research and therapies

Psychedelics research in support of brain health is getting a major boost this month with the formation of the Neuroscape Psychedelics Division at the University of California, San Francisco.

Read more News

› Verified 3 days ago


Dermatology Doctors in Pasadena, TX

William Edward Tausend, MD
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 3901 Woodlawn Ave, Pasadena, TX 77504
Phone: 713-946-2666    
Dr. Manuel Davila, MD
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 4419 Crenshaw Rd, Pasadena, TX 77504
Phone: 281-991-5944    Fax: 281-991-6129
Whitney Anne Latin, M.D.
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 5125 Preston Ave # 150, Pasadena, TX 77505
Phone: 281-991-0737    Fax: 281-991-0738
Dr. Paula F Leis, MD
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 4419 Crenshaw Rd, Pasadena, TX 77504
Phone: 281-991-5944    Fax: 281-991-6129
Christine M Hunt, M.D.
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 4419 Crenshaw Rd, Pasadena, TX 77504
Phone: 281-991-5944    
Dr. Lawrence M. Joseph, M.D.
Dermatology
Medicare: Not Enrolled in Medicare
Practice Location: 4419 Crenshaw Rd, Pasadena, TX 77504
Phone: 281-991-5944    Fax: 281-991-6849

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.